Indian pharma sector can grow to 65 billion dollar industry by 2024: Sadananda Gowda


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Indian pharma sector can grow to 65 billion dollar industry by 2024: Sadananda Gowda
Indian Pharma Industry on upbeat following the pandemic

Chemicals and Fertilizers Minister DV Sadananda Gowda said India is one of the largest manufacturers and exporters of generic medicines across the world. Addressing the Latin America and Caribbean Session on ‘Reimagining Distances’, through virtual mode Mr Gowda said, Indian pharma sector can grow to 65 billion dollar industry by the year 2024.

Referring to the supply of HCQ and Azithromycin for treatment of Covid-19 cases, he said, India has supplied these medicines to more than 120 countries. He underlined that India has earned the reputation of a reliable supplier of medicines in the world.

Mr Gowda said the government has recently launched schemes for development of seven mega parks including three bulk drug parks and four medical devices parks across the country. He invited the investors to set up a manufacturing base in India in the pharma sector. The Minister said the market size of Chemicals & Petrochemicals sector in India is around 165 billion dollars and is expected to grow up to 300 billion dollars by the year 2025.

Meanwhile, Health Minister Dr Harsh Vardhan today reviewed the activities taken under the “Jan Andolan” on COVID Appropriate Behaviour with the Heads of all AIIMS and Central Government Hospitals through video conferencing.

Highlighting the importance of the coming months in the country’s collective fight against the pandemic, Dr Vardhan said the government has created the significant infrastructure for our fight against COVID which includes over 90 lakh beds, over 12,000 quarantine centres and more than 1900 labs.

He stated that the next two and half months are going to be very crucial for us in our fight against corona because of the winter season and the festival season. He said it becomes the responsibility of every citizen to follow COVID appropriate behaviour to curb the spread of the infection.”

The Health Minister stressed on the importance of physical distancing for effective containment of the disease.

The Union Minister asked all the heads of medical institutions to be the frontrunners in showcasing the importance of this Social Vaccine to break the chain of transmission of the disease in the country.

On India’s fight against COVID-19, Dr Vardhan said, India is continuously recording new milestones in the treatment of Covid. He said, India also has now become self-reliant in terms of masks and PPE kits which we earlier used to import.

Tags : #SadanandaGowda #IndiaPharmaSector #65BillionIndustry2024 #AIIMS #DrHarshVardhan #JanAndolan #ReimaginingDistances

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026